Author:
Gil-Martínez Ana-Luisa,Cuenca Lorena,Sánchez Consuelo,Estrada Cristina,Fernández-Villalba Emiliano,Herrero María Trinidad
Funder
Ministerio de Educación, Cultura y Deporte
Fundación Séneca
FP7 Ideas: European Research Council
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Neurology,Immunology,General Neuroscience
Reference43 articles.
1. Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386(9996):896–912.
2. Pérez-Otaño I, Oset C, Luquin MR, Herrero MT, Obeso JA, Del Río J. MPTP-induced parkinsonism in primates: pattern of striatal dopamine loss following acute and chronic administration. Neurosci Lett. 1994;175(1–2):121–5.
3. Blesa J, Przedborski S. Parkinson’s disease: animal models and dopaminergic cell vulnerability. Front Neuroanat. 2014;8:1–12.
4. Li B-D, Bi Z-Y, Liu J-F, Si W-J, Shi Q-Q, Xue L-P, et al. Adverse effects produced by different drugs used in the treatment of Parkinson’s disease: a mixed treatment comparison. CNS Neurosci Ther. 2017;23(10):827–42.
5. Brundin P, Barker RA, Conn PJ, Dawson TM, Kieburtz K. Linked clinical trials – the development of new clinical learning studies in Parkinson’s disease using screening of multiple prospective new treatments. J Park Dis. 2015;3(3):231–9.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献